We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
We Are Colony are a global film streaming platform that are connecting filmmakers to fans through exclusive content.  
days to go: Expired investment: £443,106
Feed is a platform that automates digital advertising for musicians and creators by enabling them to grow an audience and build their businesses. The creator needs to connect their social media accounts to the Feed portal and set a budget. The portal will then create ads that reach new people and convert engaged audiences into loyal fans over time. The company asserts that existing ad generation platforms are too complex, time-consuming and expensive for creators. Feed argues that its portal caters to a variety of budgets, requires no marketing knowledge and takes minutes to get started. The beta platform is integrated with Facebook's & Instagram's ad network and has 500 creators on board. The company will use the investment to launch the paid version of Feed in Q4 2020. 

Pitch Rated

47%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £146,117
Polysolar specialises in manufacturing photovoltaic windows capable of generating electricity, which can be used in buildings to generate clean renewable energy whilst also meeting planning regulations. Its technology is already in-use by major organisations such as Network Rail and Sainsbury's.

Pitch Rated

69%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,311,180
Actve is on a mission to change the way people connect with their favourite fitness creators. The company aspires to help creators earn an income and build a subscription business. Actve asserts that it caters to a variety of creator needs allowing them to live-stream their workouts, offer guided programs to customers, or use Actve's software to manage their clients. The company aims to become a contender in the digital fitness market that is projected to be worth £21 billion by 2022. It aims to launch its platform in September 2021. Actve will use the investment to develop its platform, hire key staff, build its user base, and work towards becoming an industry champion for fitness creators.
days to go: Expired investment: £165,627
Doctaly is  the brand new healthcare platform providing the quickest way to find and book an affordable, face-to-face, same day GP appointment. Choose from their trusted private doctors, at a convenient time and location from just £39.99.
days to go: Expired investment: £807,580
The Market Mogul are a Millennial media company, publishing unique perspective of the main global events in our time. They are already backed by a VC fund and have built an engaged readership and over 3000 authors. They will be using this round of funding to expand the editorial and sales teams and launch new verticals. 
days to go: Expired investment: £729,950
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go: Expired investment: £136,827
The GP Service is a web and application-based platform that provides private consultations for patients across the UK. The aim is to provide a safe and easy journey for individuals who are looking for private medical treatment at their convenience and at an affordable cost. They have established a connection with over 1600 pharmacies across the UK. They have an excellent 5-star trust pilot rating and also are 1st Private Online Provider which has access to NHS Medical Records. With the proceeds, the company will scale the enterprise offering, increase brand awareness and also launch additional revenue opportunities.

Pitch Rated

77%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £907,540
Rescape is a company pioneering the use of Virtual Reality (VR) in healthcare and frontline services. Its DR.VR platform, launched in 2019, helped reduce pain and anxiety amongst patients in hospitals and care homes. The company delivers VR content to patients through the Samsung Gear VR headset, a hard-plastic headset, that can be wiped down and disinfected along with VR sanitary eye masks that reduce chances of infection and irritation to patients. Through the company's technology, patients can experience ocean life, amusements parks and relax in some of the most beautiful settings in the world, all from the safety of the healthcare institution. The AR/VR in Healthcare Market is predicted to reach USD 30-40 billion by 2026, and Rescape aims to be a disruptor in this segment. The company will use the investment to grow its business across different verticals.

Pitch Rated

66%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £488,450
BlueJay are a social radio which allow the user to create their very own livestream playlist which they can share with a small group of friends or thousands of followers. BlueJay is a free music app available on Android and IOS and allows users to share their own music or follow their favourite artists or friends to discover new music. 
days to go: Expired investment: £153,788
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph